Cargando…

Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma

INTRODUCTION: The poorly differentiated pancreatic adenocarcinoma (PDAC) is an extremely lethal neoplasm without effective biomarkers for early detection and prognosis prediction, which is characteristically unresponsive to chemotherapeutic regimens. This study aims at searching for key genes which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yuanxiang, Li, Dongxiao, Liu, Ge, Xiao, Erwei, Mu, Senmao, Pan, Yujin, Qin, Fangyuan, Zhai, Yaping, Duan, Shaofeng, Li, Deyu, Yan, Guoyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850576/ https://www.ncbi.nlm.nih.gov/pubmed/33536763 http://dx.doi.org/10.2147/OTT.S279287

Ejemplares similares

Identification of critical pathways and potential therapeutic targets in poorly differentiated duodenal papilla adenocarcinoma
por: Lu, Yuanxiang, et al.
Publicado: (2021)

Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma
por: Ge, Jiachen, et al.
Publicado: (2022)

Preoperative Oral Carbohydrate Levels in Patients with Type 2 Diabetes Mellitus: The Clinical Guiding Significance of Free Fatty Acids
por: Yang, Jiuhui, et al.
Publicado: (2022)

Portal Venous Circulating Tumor Cells Undergoing Epithelial-Mesenchymal Transition Exhibit Distinct Clinical Significance in Pancreatic Ductal Adenocarcinoma
por: Pan, Yujin, et al.
Publicado: (2021)

Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
por: Wang, Li, et al.
Publicado: (2016)

Laparoscopic splenectomy: posterolateral approach in patients with liver cirrhosis and portal hypertension with platelet count lower than 1 × 10(9)/l
por: Tian, Guangjin, et al.
Publicado: (2018)

PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Ge, Ouyang, et al.
Publicado: (2021)

Adult pancreatic cavernous hemangioma: case presentation of a benign tumor with a complex composition
por: Lianyuan, Tao, et al.
Publicado: (2019)

Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma
por: Ren, Shuai, et al.
Publicado: (2020)

Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus
por: Yang, Fangyuan, et al.
Publicado: (2019)

Key drug-targeting genes in pancreatic ductal adenocarcinoma
por: Sakharkar, Meena Kishore, et al.
Publicado: (2021)

Key microRNAs and hub genes associated with poor prognosis in lung adenocarcinoma
por: Ye, Guan-Chao, et al.
Publicado: (2021)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Paraneoplastic Leukocytosis: A Poor Prognostic Marker in Pancreatic Adenocarcinoma
por: Kabashneh, Sohaip, et al.
Publicado: (2020)

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
por: Wang, Lili, et al.
Publicado: (2017)

High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma
por: Liu, Na, et al.
Publicado: (2021)

Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images
por: Ren, Shuai, et al.
Publicado: (2019)

Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma
por: Hu, Xi, et al.
Publicado: (2021)

The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients
por: Xing, Yasi, et al.
Publicado: (2022)

A Nomogram for Individual Prediction of Poor Prognosis After Radical Surgery in Patients with Primary Pancreatic Duct Adenocarcinoma
por: Zhai, Shuyu, et al.
Publicado: (2020)

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
por: Zhang, Luan-Jing, et al.
Publicado: (2014)

Exploring the key genetic association between chronic pancreatitis and pancreatic ductal adenocarcinoma through integrated bioinformatics
por: Guo, Kai, et al.
Publicado: (2023)

KRAS as a Key Oncogene in the Clinical Precision Diagnosis and Treatment of Pancreatic Cancer
por: Dai, Manxiong, et al.
Publicado: (2022)

Actin gamma 1 is a critical regulator of pancreatic ductal adenocarcinoma
por: Tang, Yichen, et al.
Publicado: (2021)

XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma
por: Birnbaum, David Jérémie, et al.
Publicado: (2019)

High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma
por: Li, He, et al.
Publicado: (2020)

Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data
por: Li, Nan, et al.
Publicado: (2019)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma
por: Huang, Xinyang, et al.
Publicado: (2022)

3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenocarcinoma
por: Liu, Xinyuan, et al.
Publicado: (2021)

Expression, prognostic value and mechanism of SP100 family in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2023)

Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?
por: Slapak, Etienne J., et al.
Publicado: (2020)

KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma
por: Li, Yuexian, et al.
Publicado: (2021)

GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma
por: Liu, Ying, et al.
Publicado: (2022)

Nectin expression in pancreatic adenocarcinoma: nectin-3 is associated with a poor prognosis
por: Izumi, Hideki, et al.
Publicado: (2015)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis
por: Tian, Chengming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ei1jvrihi6li96tf430pmiv5n